In this episode of the Psychedelic Spotlight Podcast, we delve deep into PSYC's latest developments and future directions. CEO David Flores shares an in-depth update, shedding light on the company’s strategic milestones and the broader impact on the psychedelic sector.

On this episode of the Psychedelic Spotlight Podcast, we dive into a critical discussion sparked by the recent news surrounding Matthew Perry’s passing and its consequent impact on public perception of ketamine and other psychedelics used in therapeutic settings.